Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | CASP1 | P29466 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | TNF | P01375 | 1/20 | 0.44 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
| ▸ | KDR | P35968 | 1/20 | 0.44 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | CASP7 | P55210 | 1/20 | 0.44 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2624869 | 0.86 | CASP1 (0.47) | ALDH1A1TDP1KDM4ECASP1ALOX15 | |
| SCHEMBL7290933 | 0.81 | ALDH1A1 (0.36) | ALDH1A1TDP1KDM4ECASP1ALOX15 | |
| SCHEMBL3037420 | 0.81 | MAOB (0.54) | ALDH1A1TDP1KDM4EALOX15HSD17B10 | |
| SCHEMBL16022012 | 0.78 | CASP1 (0.47) | ALDH1A1KDM4ECASP1ALOX15HSD17B10 | |
| SCHEMBL12374357 | 0.78 | TRPA1 (0.46) | ALDH1A1TDP1KDM4EALOX15HSD17B10 | |
| SCHEMBL24445914 | 0.78 | CA3 (0.40) | ALDH1A1TDP1HPGDTRIM24ALDH5A1 | |
| SCHEMBL1012820 | 0.78 | ALDH1A1 (0.67) | ALDH1A1TDP1KDM4EHSD17B10HPGD | |
| SCHEMBL28459787 | 0.77 | ALDH1A1 (0.44) | ALDH1A1TDP1KDM4ECASP1ALOX15 | |
| SCHEMBL17498275 | 0.75 | CA1 (0.52) | ALDH1A1TDP1KDM4ECASP1ALOX15 | |
| SCHEMBL16704450 | 0.75 | TRPA1 (0.62) | ALDH1A1TDP1KDM4ECASP1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150306237-A1 | HYALURONIC ACID-ANTIOXIDANT CONJUGATES AND THEIR USES | UNIVERSITY OF GENEVA (CH) | 2015-10-29 | — | — | US | disclosed |
| US-8883462-B2 | Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer | TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY TLO CO., LTD. (JP) | 2014-11-11 | — | — | US | disclosed |
| US-8754197-B2 | Synthesis of azo bonded immunoregulatory compounds | BIOCON LIMITED (IN) | 2014-06-17 | — | — | US | disclosed |
| US-20130096286-A1 | SYNTHESIS OF AZO BONDED IMMUNOREGULATORY COMPOUNDS | BIOCON LIMITED (IN) | 2013-04-18 | — | — | US | disclosed |
| US-8314214-B2 | Synthesis of azo bonded immunoregulatory compounds | BIOCON LIMITED (IN) | 2012-11-20 | — | — | US | disclosed |
| US-8175860-B2 | Method of inhibiting the growth of Helicobacter pylori | NATIONAL TSING HUA UNIVERSITY (TW) | 2012-05-08 | — | — | US | disclosed |
| US-20120100579-A1 | TRIPRENYL PHENOL COMPOUND, PROCESS FOR PRODUCTION OF TRIPRENYL PHENOL COMPOUND, AND THROMBOLYSIS ENHANCER | TOKYO UNIVERSITY OF AGRICLATURE AND TECHNOLOGY TLO CO., LTD. (JP) | 2012-04-26 | — | — | US | disclosed |
| US-20110201792-A1 | SYNTHESIS OF AZO BONDED IMMUNOREGULATORY COMPOUNDS | BIOCON LIMITED (IN) | 2011-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130096286-A1 | SYNTHESIS OF AZO BONDED IMMUNOREGULATORY COMPOUNDS | C3AR1, HRH4, FCGRT | ALDH1A1 836/4885TDP1 4629/4885KDM4E 2574/4885 |
| US-20150306237-A1 | HYALURONIC ACID-ANTIOXIDANT CONJUGATES AND THEIR USES | CD44, HAO2, LPO | ALDH1A1 84/4885TDP1 1898/4885KDM4E 4231/4885 |
| US-20110201792-A1 | SYNTHESIS OF AZO BONDED IMMUNOREGULATORY COMPOUNDS | CBR1, CBR3, HRH4 | ALDH1A1 75/4885TDP1 4148/4885KDM4E 1902/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.